GHRL and colitis: Furthermore, in a mouse model of trinitrobenzene sulfonic acid-induced colitis, ghrelin effectively downregulated Th1 cell-induced autoimmune responses and the production of inflammatory mediators, thereby safeguarding the GI barrier, mitigating weight loss, reducing diarrhea, decreasing mortality rates, and preventing disease recurrence [81].